RESPONSE: re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma
Hortobagyi
GN
Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston.
Buzdar
AU